Consun Pharmaceutical Group Management
Management criteria checks 2/4
Consun Pharmaceutical Group's CEO is Meng An, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is CN¥16.76M, comprised of 6.6% salary and 93.4% bonuses, including company stock and options. directly owns 1.83% of the company’s shares, worth HK$91.50M. The average tenure of the management team and the board of directors is 3.5 years and 3.5 years respectively.
Key information
Meng An
Chief executive officer
CN¥16.8m
Total compensation
| CEO salary percentage | 6.6% |
| CEO tenure | less than a year |
| CEO ownership | 1.8% |
| Management average tenure | 3.5yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30
Jun 01
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20
Apr 28Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20
Apr 07Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Aug 26Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?
Mar 17Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative
Feb 19How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 29Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?
Jan 08
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?
Nov 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥785m |
| Sep 30 2023 | n/a | n/a | CN¥759m |
| Jun 30 2023 | n/a | n/a | CN¥734m |
| Mar 31 2023 | n/a | n/a | CN¥708m |
| Dec 31 2022 | CN¥17m | CN¥1m | CN¥683m |
| Sep 30 2022 | n/a | n/a | CN¥660m |
| Jun 30 2022 | n/a | n/a | CN¥636m |
| Mar 31 2022 | n/a | n/a | CN¥613m |
| Dec 31 2021 | CN¥14m | CN¥670k | CN¥590m |
Compensation vs Market: Meng's total compensation ($USD2.32M) is above average for companies of similar size in the Hong Kong market ($USD476.87K).
Compensation vs Earnings: Meng's compensation has increased by more than 20% in the past year.
CEO
Meng An (52 yo)
less than a year
Tenure
CN¥16,760,000
Compensation
Mr. Meng An serves as Executive Chairman of the Board at Consun Pharmaceutical Group Limited since July 9, 2021 and serves a sits Chief Executive Officer from January 17, 2024. Mr. An being the Chairman of...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | less than a year | CN¥16.76m | 1.83% CN¥ 91.5m | |
| Chief Scientist & Executive Director | 3.5yrs | CN¥3.78m | no data | |
| Assistant GM | 3.2yrs | CN¥755.00k | no data | |
| CFO & VP | 4.2yrs | no data | no data | |
| Assistant President | 4.3yrs | no data | no data | |
| Board Secretary | 10.1yrs | no data | no data | |
| Company Secretary | 11.2yrs | no data | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 3.5yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 3.5yrs | no data | no data |
3.5yrs
Average Tenure
53yo
Average Age
Experienced Management: 1681's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Chairman | 3.2yrs | CN¥16.76m | 1.83% CN¥ 91.5m | |
| Chief Scientist & Executive Director | 11.4yrs | CN¥3.78m | no data | |
| Assistant GM | 3.2yrs | CN¥755.00k | no data | |
| Chairman & GM of Guangxi Yulin Pharmaceutical Group Co. Ltd | 3.5yrs | no data | no data | |
| Chairman & GM of Consun Pharmaceutical(Inner Mongolia) Co. Ltd | 3.5yrs | no data | no data | |
| Independent Non-Executive Director | 10.4yrs | CN¥144.00k | no data | |
| Independent Non Executive Director | 5yrs | CN¥144.00k | no data | |
| Non-Executive Director | 2.8yrs | no data | no data |
3.5yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 1681's board of directors are considered experienced (3.5 years average tenure).